60
Participants
Start Date
December 16, 2021
Primary Completion Date
September 30, 2025
Study Completion Date
November 30, 2025
Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA
In this study, we propose a pragmatic, pilot, open-label trial where we are comparing adherence to different inhaler regimens. Patients who were previously sub-optimally adherent to maintenance ICS inhalers will either continue receiving maintenance ICS inhalers and symptom-driven SABA inhalers or symptom-driven ICS/LABA inhalers only.
Washington University in St. Louis School of Medicine, St Louis
National Institutes of Health (NIH)
NIH
National Center for Advancing Translational Sciences (NCATS)
NIH
Washington University School of Medicine
OTHER